AKT1 and renal cell carcinoma: In RCC cells, PI3K-AKT-mTOR pathway was activated with decreased METTL3 expression as indicated by increased phosphorylation of the components of this pathway such as p-PI3K, p-AKT, p-mTOR, and p-P70.